3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Ovarian Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Urogenital Neoplasms
3
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
tislelizumab
3
toripalimab
1
tazemetostat
1
sintilimab
1
pembrolizumab
1
osimertinib
1
enzalutamide
1
envafolimab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Specimen Handling
1
Radiotherapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Injections
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
aldesleukin
×
90 days
×
Clear all
No trials found.